Strategies for Recommending HPV Vaccination for Pre-Teen Youth
Originally presented on June 21, 2018
Originally presented on June 21, 2018
To prevent cervical cancer and other cancers associated with human papilloma virus (HPV) infection, the standard of care is to give HPV vaccine to children at age 11 or 12 years. However, uptake of HPV vaccine in New York State is sub-optimal, and providers express challenges in communicating about HPV vaccine to youth and their parents.
A variety of factors contribute to hesitancy among parents to vaccinate their children. Evidence shows that providing a strong recommendation for the HPV vaccine increases its uptake. Effectively addressing the specific factors that contribute to this hesitancy and hinder clear communication of the latest information about vaccine efficacy and safety may help increase the acceptance of HPV vaccine among parents and their pre-adolescents.
This webcast will consider the use of motivational interviewing and other communication strategies to help providers explore these factors with their clients and will offer concrete strategies providers can use in communicating about HPV vaccination.
Target Audience
Physicians, physician assistants, nurses, nurse practitioners, and other medical providers who counsel adolescents/pre-adolescents and their parents about vaccinations.
Kristin Oliver, MD, MHS
Assistant Professor, Department of Pediatrics, Environmental Medicine & Public Health
Icahn School of Medicine at Mt. Sinai
As a result of this activity, the learner will be able to enhance their knowledge and competence on concrete communication strategies providers can use to effectively communicate information about HPV vaccine to increase vaccine uptake for pre-teens.
After viewing the webcast participants will be able to:
Continuing Education Credits expired for this activity on June 30, 2023. We encourage you to fill out the evaluation as your responses help us to plan future programs.